{"duration": 0.29663825035095215, "input_args": {"instruction": "\"Context: {'triple-receptor negative breast cancer': {'variants': ['rs2363956'], 'genes': ['TP53']}, 'lung adenocarcinoma': {'variants': ['rs876660333', 'rs377577594', 'rs397516975', 'rs876660754', 'rs4236709', 'rs985033810', 'rs587781991', 'rs967461896', 'rs56113850', 'rs876659675', 'rs483352697', 'rs3117582', 'rs121913428', 'rs876659802', 'rs876660821', 'rs121913275', 'rs397516436', 'rs397517102', 'rs2293607', 'rs587781525', 'rs121917759', 'rs876660807', 'rs121913370', 'rs121913315', 'rs587782664', 'rs876658468', 'rs121913469', 'rs121913284', 'rs121913385', 'rs11632038', 'rs121913529', 'rs377767347', 'rs121913281', 'rs121913331', 'rs397507484', 'rs121913530', 'rs121913500', 'rs121913343', 'rs200595745', 'rs587782329', 'rs121913361', 'rs121913403', 'rs121913351', 'rs397507546', 'rs17851045', 'rs121913482', 'rs587782289', 'rs121913495', 'rs1057519983', 'rs121913399', 'rs397516896', 'rs866775781', 'rs13314271', 'rs121913273', 'rs121913233', 'rs121913355', 'rs121913274', 'rs62560775', 'rs121913357', 'rs121913400', 'rs34968276', 'rs121434568', 'rs121913499', 'rs139429793', 'rs587776805', 'rs942158624', 'rs11639372', 'rs121913255', 'rs587782082', 'rs121913366', 'rs121913409'], 'genes': ['TERT', 'RTEL1']}}\\nAdditional Knowledge: ## Domain Knowledge:\\n\\n**Triple-receptor negative breast cancer (TNBC):**\\n* A subtype of breast cancer that lacks expression of estrogen receptor (ER), progesterone receptor (PR), and HER2/neu receptor.\\n*  Known for its aggressive nature and poor prognosis. \\n*  Often has limited treatment options due to the lack of targeted therapies. \\n\\n**Lung adenocarcinoma:**\\n* The most common type of lung cancer in non-smokers. \\n* Characterized by slow growth and spread, but can be aggressive in some cases. \\n*  Treatment options include surgery, chemotherapy, radiation therapy, and targeted therapies.\\n\\n**TERT:**\\n*  The gene encoding telomerase reverse transcriptase, an enzyme that maintains telomere length.\\n* Telomeres are protective caps at the ends of chromosomes.\\n*  TERT overexpression has been linked to cancer development and progression.\\n\\n**POU5F1B:**\\n* Also known as OCT4, a transcription factor involved in embryonic development and pluripotency. \\n*  Overexpression of POU5F1B has been implicated in certain cancers.\\n\\n**PLG:**\\n* The gene encoding plasminogen, a precursor protein involved in fibrinolysis (the breakdown of blood clots).\\n*  PLG is associated with tumor growth and metastasis.\\n\\n**IGF1R:**\\n* The gene encoding the insulin-like growth factor 1 receptor, a receptor involved in cell growth and proliferation.\\n*  IGF1R signaling is often dysregulated in cancer, promoting tumor growth and survival.\\n\\n**LRMDA:**\\n*  This gene is not directly associated with breast cancer or lung adenocarcinoma based on current research.\\n\\n## Question:\\n\\nOut of the given list, which gene is associated with triple-receptor negative breast cancer and lung adenocarcinoma?\\n\\n## Answer:\\n\\n**TERT** is the gene associated with both triple-receptor negative breast cancer and lung adenocarcinoma. \\n\\n NOTE: Above answer may be hallucination. Please provide correct answer from context only.\\nQuestion: Out of the given list, which Gene is associated with triple-receptor negative breast cancer and lung adenocarcinoma. Given list is: TERT,  POU5F1B,  PLG, IGF1R,  LRMDA\"", "system_prompt": "'You are an expert biomedical researcher. For answering the Question at the end, you need to first read the Context provided.\\nBased on that Context, provide your answer in the following JSON format for the Question asked.\\n{{\\n  \"answer\": <correct answer>\\n}}\\n'", "temperature": "0"}, "time": 1731583429.4931803}